Patents by Inventor Deanna L. Russell

Deanna L. Russell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Obesity gene and use thereof
    Patent number: 8034564
    Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human obesity and diabetes predisposing gene, specifically the TBC1D1 gene, some mutant alleles of which cause susceptibility to obesity and/or diabetes. More specifically, the invention relates to germline mutations in the TBC1D1 gene and their use in the diagnosis of predisposition to obesity and diabetes. Finally, the invention relates to the screening of the TBC1D1 gene for mutations/alterations, which are useful for diagnosing the predisposition to obesity.
    Type: Grant
    Filed: April 26, 2007
    Date of Patent: October 11, 2011
    Assignee: University of Utah Research Foundation
    Inventors: Donna M. Shattuck, Steven Stone, Deanna L. Russell, Victor Abkevich, Steven Hunt
  • DIABETES GENE
    Publication number: 20080261231
    Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect human diabetes mellitus predisposing gene, specifically the angiotensinogen (AGT) gene, some mutant alleles of which cause susceptibility to insulin-dependent diabetes mellitus (IDDM). More specifically, the invention relates to germline mutations in the AGT gene and their use in the diagnosis of predisposition to diabetes. The invention also relates to the prophylaxis and/or therapy of diabetes associated with a mutation in the AGT gene. The invention further relates to the screening of drugs for diabetes therapy. Finally, the invention relates to the screening of the AGT gene for mutations, which are useful for diagnosing the predisposition to diabetes.
    Type: Application
    Filed: April 18, 2008
    Publication date: October 23, 2008
    Applicant: MYRIAD GENETICS, INCORPORATED
    Inventors: Maura McGrail, Deanna L. Russell, Donna M. Shattuck
  • Diabetes gene
    Patent number: 7374884
    Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect human diabetes mellitus predisposing gene, specifically the angiotensinogen (AGT) gene, some mutant alleles of which cause susceptibility to insulin-dependent diabetes mellitus (IDDM). More specifically, the invention relates to germline mutations in the AGT gene and their use in the diagnosis of predisposition to diabetes. The invention also relates to the prophylaxis and/or therapy of diabetes associated with a mutation in the AGT gene. The invention further relates to the screening of drugs for diabetes therapy. Finally, the invention relates to the screening of the AGT gene for mutations, which are useful for diagnosing the predisposition to diabetes.
    Type: Grant
    Filed: May 13, 2004
    Date of Patent: May 20, 2008
    Assignee: Myriad Genetics, Inc.
    Inventors: Maura McGrail, Deanna L. Russell, Donna M. Shattuck
  • Obesity gene and use thereof
    Patent number: 7314713
    Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human obesity and diabetes predisposing gene, specifically the TBC1D1 gene, some mutant alleles of which cause susceptibility to obesity and/or diabetes. More specifically, the invention relates to germline mutations in the TBC1D1 gene and their use in the diagnosis of predisposition to obesity and diabetes. Finally, the invention relates to the screening of the TBC1D1 gene for mutations/alterations, which are useful for diagnosing the predisposition to obesity.
    Type: Grant
    Filed: September 3, 2003
    Date of Patent: January 1, 2008
    Assignees: Myriad Genetics, Inc., University of Utah
    Inventors: Donna M. Shattuck, Steven Stone, Deanna L. Russell, Victor Abkevich, Steven Hunt
  • Diabetes gene
    Patent number: 6902888
    Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect human diabetes mellitus predisposing gene, specifically the angiotensinogen (AGT) gene, some mutant alleles of which cause susceptibility to insulin-dependent diabetes mellitus (IDDM). More specifically, the invention relates to gernline mutations in the AGT gene and their use in the diagnosis of predisposition to diabetes. The invention also relates to the prophylaxis and/or therapy of diabetes associated with a mutation in the AGT gene. The invention further relates to the screening of drugs for diabetes therapy. Finally, the invention relates to the screening of the AGT gene for mutations, which are useful for diagnosing the predisposition to diabetes.
    Type: Grant
    Filed: May 16, 2000
    Date of Patent: June 7, 2005
    Assignee: Myriad Genetics, Inc.
    Inventors: Maura McGrail, Deanna L. Russell, Donna M. Shattuck
  • Diabetes gene
    Publication number: 20040265882
    Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect human diabetes mellitus predisposing gene, specifically the angiotensinogen (AGT) gene, some mutant alleles of which cause susceptibility to insulin-dependent diabetes mellitus (IDDM) . More specifically, the invention relates to germline mutations in the AGT gene and their use in the diagnosis of predisposition to diabetes. The invention also relates to the prophylaxis and/or therapy of diabetes associated with a mutation in the AGT gene. The invention further relates to the screening of drugs for diabetes therapy. Finally, the invention relates to the screening of the AGT gene for mutations, which are useful for diagnosing the predisposition to diabetes.
    Type: Application
    Filed: May 13, 2004
    Publication date: December 30, 2004
    Applicant: Myriad Genetics, Incorporated
    Inventors: Maura McGrail, Deanna L. Russell, Donna M. Shattuck